More blood cancer patients need to participate in clinical trials

communityreply@lls.org — Thu, 26 Mar 2009 20:34:33 GMT

At February’s third annual Texas Forum on Blood Cancers, Louis J. DeGennaro, PhD and chief scientific officer for The Leukemia & Lymphoma Society (LLS), stressed the need for more clinical trials for blood cancer patients.

“Companies may have drugs on the shelf that are approved for other cancers and may work in blood cancers, but haven’t been tested because of lack of money and lack of enough patients,” said DeGennaro at the opening session, “Accelerating the Development of New Blood Cancer Therapies.”

In case you didn’t know, LLS is working hard on making sure that more clinical trials are available to blood cancer patients by way of the Therapy Acceleration Program, otherwise known as TAP. The goal of the program is to bypass some of the hurdles that have typically been in place, and to make sure that patients have access to the therapies they need sooner rather than later. The patient can still expect to receive high quality treatment – it’s just going to be there sooner, which can be critical for those who are living with fast-acting cancers.

Learn more about the LLS Therapy Acceleration Program on www.LLS.org and find out more about clinical trials at www.LLS.org/clinicaltrials. Read more about the Forum in Dallas at www.curetoday.com.

Researchers: Apply for a Career Development Program Grant

communityreply@lls.org — Mon, 25 Aug 2008 16:01:57 GMT

Each year The Leukemia & Lymphoma Society (LLS) awards research grants through the Career Development Program (CDP) to professionals who do important research related to cancer, including blood cancers. This research is critical in improving cancer treatment, and potentially in cancer prevention.

If you are a researcher and would like LLS to fund your research, visit our CDP webpage where you can learn more about what we award, as well as details on what we need from you.

Here are a few details:

Your letter of intent (required) is due by 3:00pm ET on September 15
Full applications are due by 3:00pm ET on October 1.
We will use proposalCentral for both the letter of intent and full application.

For more information, including guidelines and instructions, visit the CDP webpage.

The Leukemia & Lymphoma Society Blog

More blood cancer patients need to participate in clinical trials

Researchers: Apply for a Career Development Program Grant